Expertise in
7
conditions

Xavier Causse

CHU Purpan
Toulouse, FR 
Expertise in
7
conditions
CHU Purpan
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Xavier Causse practices in Toulouse, France. Mr. Causse is highly rated in 7 conditions, according to our data. His top areas of expertise are Hepatitis, Cirrhosis, Hepatitis B, Hepatitis C, and Liver Transplant.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

CHU Purpan
Toulouse, France
Other Locations
CHU Caen
Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Follow-up of HBsAg Inactive Carriers Study
Follow-up of HBsAg Inactive Carriers Study
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Other
Study Phase: Not Applicable
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Enrollment Status: Completed
Publish Date: March 26, 2021
Intervention Type: Other
Prospective, Comparative (5 Groups), Non-randomized, Multicenter, Physiopathological Study, Evaluating Pharmacokinetic Characteristics of Serum Hepcidin Level in Response to Iron Oral Intake in Order to Evaluate Their Interest to Discriminate Patients With Dysmetabolic Hepatosiderosis or Ferroportin Disease.
Prospective, Comparative (5 Groups), Non-randomized, Multicenter, Physiopathological Study, Evaluating Pharmacokinetic Characteristics of Serum Hepcidin Level in Response to Iron Oral Intake in Order to Evaluate Their Interest to Discriminate Patients With Dysmetabolic Hepatosiderosis or Ferroportin Disease.
Enrollment Status: Completed
Publish Date: March 27, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

43 Total Publications

Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.
Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.
Journal: Journal of viral hepatitis
Published: September 10, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Causse's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile